The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day.

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK Leibniz Institute (IPK) and the Karlsruhe Institute of Technology (KIT) ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $43.42, moving -1.83% from the previous trading session.

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

EditCo Bio, a leader in cutting-edge genetic engineering and cellular model solutions, today announced the launch of XDel Knockout Cells, an innovative product designed to revolutionize the field of ...

Advancements and Projections in the Global Zebrafish for Research Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew York, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Overview The Global ...

The Global Digital Medicine market is experiencing significant growth driven by several key market drivers. Increased smartphone penetration ...

Pathology Lab Equipment Market Growth Secured At 6.37% CAGR To Achieve 25.0 Billion USD By 2032 Leica Biosystems The Global Pathology Lab Equipment market is driven by several key factors, including ...

DeepSeek was tasked with selecting two stocks investors can buy now and hold long-term due to their growth potential.

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...

Neurons may get all the glory, but they would be nothing without glial cells. While brain cells do the heavy lifting in the nervous system, it's the glia that provide nutrients, clean up waste, and ...